跳至主要内容
临床试验/DRKS00030936
DRKS00030936招募中Unknown

Research project to test the efficacy of an online follow-up program for patients with anxiety disorder using randomized controlled designs

Sympatient GmbH0 个研究点目标入组 414 人开始时间: 2022年12月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
414

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • ? Presence of a primary diagnosed anxiety disorder (for RCT-A: agoraphobia with/without panic disorder F40.0-/6B32; for RCT-P: panic disorder F41.0/6B34; for RCT-S: social phobia F40.1/6B34).
  • ? Current, at least mild, anxiety symptomatology as measured by a summed score of at least 30 on the LSAS for the RCT-S, or at least 8 on the PAS for the RCT-A and RCT-P at the time of baseline interview (T0)
  • ? One prior psychotherapeutic treatment for the anxiety disorder completed within the past 12 months
  • ? No current medication for the anxiety disorder or medication stable for at least 4 weeks before inclusion
  • ? Presence of internet access and a device to use Invirto Aftercare.
  • ? Sufficient understanding of the German language
  • ? Willingness to use Invirto Nachsorge on their own responsibility.

排除标准

  • ?Acute suicidality
  • ?Current ongoing psychotherapeutic treatment at baseline assessment
  • ?Diagnosis of schizophrenic or bipolar disorder
  • ?Contraindication to the Invirto aftercare medical device

研究者

发起方
Sympatient GmbH

相似试验